SK pharmteco recently participated in a roundtable discussion with “Pharma’s Almanac” titled “How Can Life Science Technology Providers Support the Pharmaceutical Industry in the Transition Toward More Digitally Connected Operations?“. In this article, you’ll hear insights from industry leaders, including Avi Nandi, Head of U.S. Cell & Gene Therapy at SK pharmteco. Avi shares:
Life science technology providers can act as catalysts for the pharmaceutical industry’s shift toward digitally connected operations by offering a suite of solutions that bridge inefficiencies and enhance transparency across the entire drug life cycle, such as:
- Integrated Digital Platforms to streamline communication and collaboration between researchers, developers, manufacturers, and distributors through a unified digital platform.
- Equipe pharmaceutical companies with real-time data analytics tools to gather and analyze real-time data, leading to optimized decision-making and process improvement.
- Implement digital solutions that provide complete visibility into the pharmaceutical supply chain, enabling companies to track materials, ensure timely delivery, and optimize logistics.
- Integrate automation and robotics into manufacturing processes to boost efficiency, minimize errors, and expedite production timelines.
- Enable remote monitoring and control of manufacturing operations via IoT-enabled devices and cloud platforms, fostering greater flexibility and agility in response to market fluctuations.
- Offer digital tools and services that streamline regulatory compliance, such as electronic batch records and e-signatures, to expedite drug approvals.
Read the full article: https://www.pharmasalmanac.com/articles/how-can-life-science-technology-providers-support-the-pharmaceutical-industry